2015
DOI: 10.2215/cjn.09901014
|View full text |Cite
|
Sign up to set email alerts
|

Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection

Abstract: Background and objectives Recent studies highlighting a role of C4d2 antibody-mediated rejection (ABMR) have debated whether C4d staining has independent value as a rejection marker. Considering the presumed role of complement as an important effector of graft injury, this study hypothesized that capillary C4d, a footprint of antibody-triggered complement activation, indicates a particularly severe manifestation of ABMR.Design, setting, participants, & measurements This large retrospective clinicopathologic st… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
39
2
1

Year Published

2016
2016
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(44 citation statements)
references
References 44 publications
(63 reference statements)
2
39
2
1
Order By: Relevance
“…Antibodies bound to HLA on endothelial cells can engage Fc receptors on NK cells or macrophages and elicit antibody-dependent cellular cytotoxicity (22). However, in contrast to our findings, C4d-positive AMR after kidney transplantation is associated with worse allograft survival than C4d-negative AMR (23, 24). This raises the suspicion that the lack of C4d deposition in some cases in our cohort is a false negative due to methodological problems with the assay rather than complement-independent pathways.…”
Section: Discussioncontrasting
confidence: 99%
“…Antibodies bound to HLA on endothelial cells can engage Fc receptors on NK cells or macrophages and elicit antibody-dependent cellular cytotoxicity (22). However, in contrast to our findings, C4d-positive AMR after kidney transplantation is associated with worse allograft survival than C4d-negative AMR (23, 24). This raises the suspicion that the lack of C4d deposition in some cases in our cohort is a false negative due to methodological problems with the assay rather than complement-independent pathways.…”
Section: Discussioncontrasting
confidence: 99%
“…1,2 The concept of alloantibody-triggered CP activation as a trigger of rejection is indirectly supported by 2 clinical observations: (1) capillary C4d in antibody-mediated rejection (ABMR), a marker of intragraft CP activation, is an independent predictor of adverse (ABO-compatible) allograft survival, 3,4 and (2) C1q-fixing donor-specific antibodies (DSA) confer a greater risk of rejection and graft failure than non-C1q-fixing antibodies. 1,2 The concept of alloantibody-triggered CP activation as a trigger of rejection is indirectly supported by 2 clinical observations: (1) capillary C4d in antibody-mediated rejection (ABMR), a marker of intragraft CP activation, is an independent predictor of adverse (ABO-compatible) allograft survival, 3,4 and (2) C1q-fixing donor-specific antibodies (DSA) confer a greater risk of rejection and graft failure than non-C1q-fixing antibodies.…”
mentioning
confidence: 99%
“…If present, C4d positivity is considered to be very specific for ABMR 48,49 and has been associated with an adverse outcome. 50 In our study, 71% and 48% of biopsies, classified as ‘suspicious for acute/active ABMR’ and acute/active ABMR, were C4d negative, but showed at least moderate microvascular inflammation. This is an interesting finding.…”
Section: Discussionmentioning
confidence: 45%